Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Perrotti A"'
Autor:
Jaclyn Heilman, Waed Alswealmeen, Gabrielle Perrotti, Steven A. Fassler, Soo Young Kim, Kirran Bakshi, Lili Sadri, David M Zebley
Publikováno v:
Clinical colorectal cancer. 21(2)
Introduction: Colorectal cancer screening improved outcomes for patients diagnosed between the age of 45-75. Present life expectancy is beyond this limit, yet there are no guidelines for these ages. We aim to identify outcomes after screening and int
Autor:
J. Solmita, Roberta Cianci, L. Gasparini, A. Delli Pizzi, F. Perrotti, M. Di Tommaso, M. Di Nicola, I.A.L. Zecca, Luciana Caravatta, Consuelo Rosa, Domenico Genovesi, Raffaella Basilico, Stephanie Sartori
Publikováno v:
Cancer/Radiothérapie. 23:216-221
Purpose To retrospectively evaluate the inter-observer agreement between a radiologist and a radiation oncologist and volume differences, in T2 and diffusion-weighted (DWI) MRI of gross tumor volume (GTV) delineation, in rectal cancer patients. Mater
Autor:
Marianna Nuzzo, Maria Daniela Falco, M. Di Tommaso, C. Di Carlo, S. Giancaterino, F. Perrotti, Antonietta Augurio, Domenico Genovesi, Luciana Caravatta, Marianna Trignani, Annamaria Vinciguerra
Publikováno v:
Cancer/Radiothérapie. 22:120-125
The aim of our study was to evaluate hippocampal irradiation in patients treated with fractionated stereotactic brain radiotherapy.Retrospective hippocampal dosimetric analysis performed on 22 patients with one to four brain metastases treated with f
Autor:
Clelia Di Carlo, Carmen Cefalogli, Marianna Nuzzo, Luciana Caravatta, F. Perrotti, Marianna Trignani, Ambra Pamio, Lucia Anna Ursini, Domenico Genovesi, Marta Di Nicola
Publikováno v:
In Vivo. 31:151-158
Aim To evaluate locoregional recurrence, overall survival, disease-free survival and prognostic influence of the number of positive lymph nodes and other variables in breast cancer treatment. Patients and methods A total of 377 patients with pT1-T2,
Autor:
Corrado Spatola, Giada Maria Vecchio, Antonio Di Cataldo, Salvatore Perrotti, Dorotea Bosco, Rosalia Latino
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-6 (2019)
World Journal of Surgical Oncology
World Journal of Surgical Oncology
Background Neuroendocrine tumors are a group of rare neoplasms, and the pancreatic neuroendocrine tumors (PNETs) represent only 1–2% of all pancreatic malignant tumors. The most common sites of these tumors include the gastrointestinal tract, lung,
Autor:
Debora Saltarelli, Alessio Perrotti, William Arcese, Francesco Marchesi, Andrea Mengarelli, Luca Cupelli, Fabio Sollazzo, Mirko Di Venanzio, Valeria Tomarchio, A Bruno, Gottardo De Angelis, Anna Chierichini, Ombretta Annibali, Paolo de Fabritiis, Luciano Delbono, Monica Piedimonte, Andrea Tendas, Pasquale Niscola
High-dose melphalan (HDMel) is the most common conditioning chemotherapy regimen for autologous stem cell transplantation (SCT) in patients affected by multiple myeloma (MM). No consensus exists for the emetogenicity or prophylaxis of chemotherapy-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e862d0857c719ab3cd6df4aeb21b8db
http://hdl.handle.net/2108/232694
http://hdl.handle.net/2108/232694
Autor:
Justine V. Cohen, Thuy Tran, Elizabeth Perrotti, Christopher R. Zito, Mario Sznol, James B. Yu, Sarah B. Goldberg, Veronica Chiang, Yuval Kluger, Upendra P. Hegde, Lucia B. Jilaveanu, RN Amanda Ralabate, Harriet M. Kluger, Wei Wei, Amit Mahajan, Sarah A. Weiss, Gail Anderson
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37(1)
Purpose Pembrolizumab is active in melanoma, but activity in patients with untreated brain metastasis is less established. We present long-term follow-up of pembrolizumab-treated patients with new or progressing brain metastases treated on a phase II
Autor:
Alison Walker, Jihane Khalife, Yan Jin, Sebastian Schwind, Malori A. Lankenau, Bo Yu, Xiaomeng Huang, Pia Hoellerbauer, Hongyan Wang, Ramasamy Santhanam, Chi-Ling Chiang, Danilo Perrotti, Somayeh S. Tarighat, Ann-Kathrin Eisfeld, Guido Marcucci, Ly James Lee, Clara D. Bloomfield, Robert J. Lee
Publikováno v:
Oncotarget
// Xiaomeng Huang 1, 2, 3, * , Sebastian Schwind 3, * , Ramasamy Santhanam 3 , Ann-Kathrin Eisfeld 3 , Chi-ling Chiang 2, 3 , Malori Lankenau 3 , Bo Yu 2, 4 , Pia Hoellerbauer 3 , Yan Jin 2 , Somayeh S. Tarighat 1, 3 , Jihane Khalife 1, 3 , Alison Wa
Autor:
Monica Di Tommaso, Antonietta Augurio, Consuelo Rosa, Domenico Genovesi, Luciana Caravatta, F. Perrotti, Isaia Al Zecca, Annamaria Vinciguerra, Marta Di Nicola, A. Allajbej, Marco Regoli
Publikováno v:
Tumori. 104(2)
Purpose: To report long-term effects on anorectal function and bowel disorders and late toxicity rate of preoperative chemoradiotherapy in patients with locally advanced rectal cancer. Methods: Between 2000 and 2016, 201 patients treated with differe
Autor:
Rossana Trotta, Manfred Kraus, Maria R. Baer, Karthika Natarajan, Eduardo Davila, Dennis Huszar, Patrick R. Baldwin, Kshama A. Doshi, Rena G. Lapidus, Mario Scarpa, Trevor J. Mathias, Shivani Kapoor, Adriana E. Tron, Danilo Perrotti
Purpose: fms-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) is present in 30% of acute myeloid leukemia (AML), and these patients have short disease-free survival. FLT3 inhibitors have limited and transient clinical activity, and concu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13e820063b3bfac9e171485cfa0e7870
https://europepmc.org/articles/PMC6444348/
https://europepmc.org/articles/PMC6444348/